Difference between revisions of "Template:DNA antivirals"
Jump to navigation
Jump to search
imported>Kwamikagami m (sp.) |
(fomivirsen withdrawn) |
||
| (29 intermediate revisions by 20 users not shown) | |||
| Line 1: | Line 1: | ||
{{Navbox | {{Navbox | ||
| − | | name | + | | name = DNA antivirals |
| − | | title = [[DNA virus]] [[antivirals]] (primarily [[ATC code J05|J05]], also [[ATC code S01#S01AD|S01AD]] and [[ATC code D06#D06BB|D06BB]]) | + | | title = [[DNA virus]] [[Antiviral drug|antivirals]] (primarily [[ATC code J05|J05]], also [[ATC code S01#S01AD|S01AD]] and [[ATC code D06#D06BB|D06BB]]) |
| − | | | + | | state = {{{state<includeonly>|autocollapse</includeonly>}}} |
| − | | | + | | listclass = hlist |
| − | |group1 | + | | group1 = [[Baltimore classification|Baltimore I]] |
| − | |list1 | + | | list1 = {{Navbox|child |
| − | | | ||
| − | | group1 = [[Herpesviridae|Herpesvirus]] | + | | group1 = [[Herpesviridae|Herpesvirus]] |
| − | | list1 | + | | list1 = {{Navbox|child |
| − | | | ||
| − | | group1 = DNA-synthesis< | + | | group1 = DNA-synthesis<br />inhibitor |
| − | | list1 | + | | list1 = {{Navbox|child |
| − | | | ||
| − | | group1 = [[Thymidine kinase from herpesvirus|TK]] activated | + | | group1 = [[Thymidine kinase from herpesvirus|TK]] activated |
| − | | list1 | + | | list1 = {{Navbox|child |
| − | | | ||
| − | | group1 = [[Purine analogue]] | + | | group1 = [[Purine analogue]] |
| − | | list1 | + | | list1 = |
| + | * ''[[guanine]]'' ([[Aciclovir]]<sup>#</sup>/[[Valaciclovir]] | ||
| + | * [[Ganciclovir]]/[[Valganciclovir]]<sup>#</sup> | ||
| + | * [[Penciclovir]]/[[Famciclovir]]) | ||
| − | ''[[adenine]]'' ([[Vidarabine | + | * ''[[adenine]]'' ([[Vidarabine]]) |
| − | | group2 = [[Pyrimidine analogue]] | + | | group2 = [[Pyrimidine analogue]] |
| − | | list2 | + | | list2 = |
| + | * ''[[uridine]]'' ([[Idoxuridine]] | ||
| + | * [[Trifluridine]] ([[Trifluridine/tipiracil|+tipiracil]]) | ||
| + | * [[Edoxudine]]) | ||
| − | ''[[thymine]]'' | + | * ''[[thymine]]'' |
| + | **[[Brivudine]] | ||
| + | **[[FV-100]]<sup>†</sup> | ||
| + | **[[Sorivudine]] | ||
| − | + | * ''[[cytosine]]'' ([[Cytarabine]]) | |
| − | + | }} | |
| − | |||
| − | + | | group2 = Not TK activated | |
| + | | list2 = | ||
| + | * [[Foscarnet]] | ||
| − | + | }} | |
| − | |||
| + | | group2 = Other | ||
| + | | list2 = | ||
| + | * [[Docosanol]] | ||
| + | * [[Maribavir]]<sup>†</sup> | ||
| + | * ''[[early protein]]'' ([[Fomivirsen]]<sup>‡</sup>) | ||
| + | * [[Tromantadine]] | ||
| − | }} | + | }} |
| + | | group2 = [[Human papillomavirus|HPV]]/[[Molluscum contagiosum|MC]] | ||
| + | | list2 = | ||
| + | * [[Imiquimod]]/[[Resiquimod]] | ||
| + | * [[Podophyllotoxin]] | ||
| − | | | + | | group3 = [[Vaccinia]] |
| − | | | + | | list3 = |
| + | * ''[[Antiviral drug#Assembly|assembly]]:'' [[Rifampicin]] | ||
| − | | | + | | group4 = [[Poxviridae]] |
| − | | | + | | list4 = |
| + | * [[Methisazone]] | ||
| + | * [[Tecovirimat]] | ||
| − | + | }} | |
| − | |||
| − | + | | group2 = [[Hepatitis B]] (VII) | |
| + | | list2 = | ||
| + | * ''[[Nucleoside analogue]]s/[[Reverse-transcriptase inhibitor#Nucleoside analog reverse transcriptase inhibitors .28NARTIs or NRTIs.29|NARTIs]]:'' [[Entecavir]]<sup>#</sup> | ||
| + | * [[Lamivudine]] | ||
| + | * [[Lobucavir]]<sup>†</sup> | ||
| + | * [[Telbivudine]] | ||
| + | * [[Clevudine]] | ||
| + | * ''[[Nucleotide analogue]]s/[[Reverse-transcriptase inhibitor#Nucleotide analog reverse transcriptase inhibitors .28NtARTIs or NtRTIs.29|NtRTIs]]:'' [[Adefovir]] | ||
| + | * [[Tenofovir disoproxil]] | ||
| + | * [[Tenofovir alafenamide]] | ||
| − | | group3 = | + | | group3 = Multiple/general |
| − | | | + | | list3 = {{Navbox|child |
| − | + | | group1 = Nucleic acid inhibitors | |
| + | | list1 = | ||
| + | * [[Cidofovir]] | ||
| + | * [[Brincidofovir]] | ||
| + | | group2 = [[Interferon]] | ||
| + | | list2 = | ||
| + | * [[Interferon alfa 2b]] | ||
| + | * [[Peginterferon alfa-2a]] | ||
| − | | | + | | group3 = Multiple/unknown |
| − | | | + | | list3 = |
| − | + | * [[Filociclovir]]<sup>†</sup> | |
| + | * [[Ribavirin]]<sup>#</sup>/[[Taribavirin]]<sup>'''†'''</sup> | ||
| + | * [[Moroxydine]] | ||
| − | + | }} | |
| − | |||
| − | | | + | | belowstyle = background: transparent; padding: 0px; |
| − | + | | below = {{PharmNavFootnote}} | |
| − | |||
| − | |||
| − | |||
| − | |||
| − | | | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
}}<noinclude> | }}<noinclude> | ||
| − | + | {{collapsible option}} | |
| − | + | [[Category:Drug templates by ATC]] | |
| − | |||
| − | [[ | ||
| − | |||
| − | |||
| − | |||
</noinclude> | </noinclude> | ||
Latest revision as of 14:47, 31 October 2020
Initial visibility: currently defaults to autocollapse
To set this template's initial visibility, the |state= parameter may be used:
|state=collapsed:{{DNA antivirals|state=collapsed}}to show the template collapsed, i.e., hidden apart from its title bar|state=expanded:{{DNA antivirals|state=expanded}}to show the template expanded, i.e., fully visible|state=autocollapse:{{DNA antivirals|state=autocollapse}}
If the |state= parameter in the template on this page is not set, the template's initial visibility is taken from the |default= parameter in the Collapsible option template. For the template on this page, that currently evaluates to autocollapse.